
Mayne Pharma shares rise 81% on A$604m takeover
Key points
- Mayne Pharma (ASX:MYX) has agreed to be acquired by Hungarian drugmaker Gedeon Richter for A$6.40 cash per share, valuing its equity at about A$604 million.
- The offer is a 99.4% premium to Mayne’s closing price on 16 November and a 124% premium to its 30-day volume-weighted average price.
- Mayne said the deal follows its agreed sale of its International business, which would leave a company focused on the United States.
Mayne Pharma (ASX:MYX) has agreed to a takeover by Hungarian drugmaker Gedeon Richter (BPSE:RICHTER) at A$6.40 cash per share, valuing Mayne’s equity at about A$604 million.
The offer is 99.4% above Mayne’s closing price on 16 November and 124% above its 30-day volume-weighted average price.
“The Board’s priority throughout has been to maximise value and certainty for all shareholders,” said Mayne Pharma Chair Professor Bruce Robinson.
The deal needs foreign investment and US antitrust approval, shareholder and court approval, and completion of Mayne’s sale of its International business to Evaris Pharma, with a A$6 million break fee payable by either side.
Mayne expects shareholders to vote in late January 2027 and the deal to be implemented in mid-to-late March 2027; following the announcement the Mayne Pharma share price was up at A$5.81.
Mayne’s board unanimously recommends the deal, subject to no superior proposal and an independent expert finding it in shareholders’ best interests, and its three largest shareholders, holding 22.14%, intend to vote in favour.
The agreement follows a failed A$7.40-a-share scheme with US-based Cosette Pharmaceuticals, signed in February 2025, which Mayne moved to terminate after Cosette sought to withdraw.
Frequently asked questions
More from Australia
Chalmers flags A$52m tax compliance savings for businesses
Western Gold names Geraghty chairman amid A$7.5m placement
Black Rock secures US$5m CRDB early drawdown
Sharon AI net loss widens to US$43.8m
Verity Resources receives approval for 10m Botswana exploration pits
Frasers urges Accent chairman to resign after 1.9% sales drop


